- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03621267
Interactive Stepping Exercise on Executive Function and Gait Variability
Effects of Interactive Stepping Exercise on Executive Function and Gait Variability in Community-dwelling Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beitou
-
Taipei, Beitou, Taiwan, 112
- Recruiting
- National Yang-Ming University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- community-dwelling older adults
- age ≥ 65 years old
- able to walk independently outdoor without an assistive device
- Mini-mental state examination ≥ 24
- use an exercise pre-participation health screening form by the American College of Sports Medicine to recruit those participants that are suitable to join the training session
Exclusion Criteria:
- diagnosed of any psychiatric and neurologic disorders such as schizophrenia, stroke, Parkinson, Alzheimer disease, etc.
- any comorbidity or disability that would preclude training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Interactive Stepping Exercise
Interactive Stepping Exercise (1 hour, 3 times/week, 12 weeks) The 1-hour training program will start with10 minutes warm-up session, after that 40 minutes of ISE, and ended with 10 minutes of cool down session. Interactive Stepping Exercise (ISE) will perform on a thin mat that was partitioned into 24 squares. The ISE program included forward, backward, lateral and oblique steps, and step patterns were progressively made more complicated. |
Interactive Stepping Exercise will perform on a thin mat, stepping pattern will display through a monitor screen, immediate auditory feedback will give for adjustment
|
|
ACTIVE_COMPARATOR: Home exercise program
60 minutes, 3 times/week, 12 weeks of home exercise
|
Home exercise program includes stretching exercise, general strengthening exercise on lower extremity muscles, posture control and balance exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trail Making Test
Time Frame: Change from Baseline at 12 weeks
|
Executive Function
|
Change from Baseline at 12 weeks
|
|
Stroop Test
Time Frame: Change from Baseline at 12 weeks
|
Executive Function
|
Change from Baseline at 12 weeks
|
|
Digit Span Test
Time Frame: Change from Baseline at 12 weeks
|
Executive Function
|
Change from Baseline at 12 weeks
|
|
Executive Interview 25 questions
Time Frame: Change from Baseline at 12 weeks
|
Executive Function
|
Change from Baseline at 12 weeks
|
|
Gait Variability
Time Frame: Change from Baseline at 12 weeks
|
Stride length and Stride time variability
|
Change from Baseline at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gait velocity
Time Frame: Change from Baseline at 12 weeks
|
Gait speed
|
Change from Baseline at 12 weeks
|
|
Stride length
Time Frame: Change from Baseline at 12 weeks
|
The distance covered by the combined step length of each limb during gait
|
Change from Baseline at 12 weeks
|
|
Stride time
Time Frame: Change from Baseline at 12 weeks
|
The time elapsed between the first contact of two consecutive footsteps of the same foot
|
Change from Baseline at 12 weeks
|
|
Functional Ambulation in community
Time Frame: Change from Baseline at 12 weeks
|
Walk for 400 m distance in community
|
Change from Baseline at 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- YM107053F
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.